论文部分内容阅读
目的 :观察非穿透小梁切除术治疗青光眼的临床疗效。方法 :对 5 5眼 3 8例青光眼患者进行非穿透小梁切除术。在浅层巩膜瓣下 ,切除层间巩膜、Schlemm′s管 (内、外 )壁、近管小梁 ,使房水在不打开前房的情况下 ,从角巩膜小梁渗出 ,从而达到降低眼压的目的 ,部分患者术中联合应用丝裂霉素和 /或植入网状透明质酸。术前、术后 1、 2、 8、 15天 ,1、 2、 3月 ,以后每 3月进行视力、眼压、裂隙灯显微镜、检眼镜等检查。结果 :术前平均眼压 3 1 65± 12 81mmHg (1mmHg =0 13 3kPa) ,术后第一天平均眼压 6 78± 2 5 3mmHg ,经 3— 12月随访 ,最后随访眼压 12 40± 3 74mmHg ,仅 2眼术后前房积血 ,均没有出现术中、术后浅前房、炎症反应等并发症。结论 :非穿透小梁切除术是一种安全、有效的抗青光眼新手术
Objective: To observe the clinical effect of non-penetrating trabeculectomy in the treatment of glaucoma. Methods: Non-penetrating trabeculectomy was performed in 45 eyes of 38 glaucoma patients. Under the superficial scleral flap, scleral sclera, Schlemm’s tube (inside and outside) wall, near the trabeculae were removed, and the aqueous humor exuded from the scleral trabeculae without opening the anterior chamber to reach Reduce the purpose of IOP, some patients intraoperative combination of mitomycin and / or reticular hyaluronic acid. Preoperative, postoperative 1, 2, 8, 15 days, 1, 2, 3 months later every March visual acuity, intraocular pressure, slit lamp microscope, ophthalmoscopy and other tests. Results: The preoperative average intraocular pressure was 3 1 65 ± 12 81mmHg (1mmHg = 0 13 3kPa). The mean intraocular pressure was 6 78 ± 2 5 3mmHg on the first day after operation. The intraocular pressure was 12 40 ± 3 74mmHg, only 2 cases of postoperative anterior chamber hemorrhage, no intraoperative, postoperative shallow anterior chamber, inflammatory response and other complications. Conclusion: Non-penetrating trabeculectomy is a safe and effective new anti-glaucoma surgery